Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Christoph Rosak"'
Autor:
Christoph Rosak, Gabriele Mertes
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
The alpha-glucosidase inhibitor acarbose has been used for more than 20 years in the management of hyperglycemia. Owing to its unique mode of action in the gastrointestinal tract, its properties are very different from other antidiabetic medications.
Autor:
Christoph Rosak, Gabriele Mertes
Publikováno v:
Current Diabetes Reviews. 5:157-164
The alpha-glucosidase inhibitor acarbose is administered to control blood glucose levels in type 2 diabetic patients and, in several countries, in those with impaired glucose tolerance. The efficacy and safety of the drug has been well established in
Autor:
Christoph Rosak
In kaum einer Subspezialität der Inneren Medizin hat es einen vergleichbaren Zuwachs an Wissen bezüglich der Pathophysiologie der Erkrankung und daraus resultierender Konsequenzen für die Therapie gegeben. Um dieser Entwicklung gerecht zu werden,
Autor:
Christoph Rosak, Rudolf A. Weiner
Publikováno v:
Visceral Medicine. 23:48-51
Diabetes mellitus is one of our most serious diseases. It accelerates the development of atherosclerosis, doubles the risk for stroke, and increases the risk of heart attacks two- to threefold. As it damages the microvasculature, diabetes produces re
Publikováno v:
Diabetes Care. 26:1738-1744
OBJECTIVE—Insulin glargine (Lantus), a long-acting human insulin analog, provides effective glycemic control when administered at bedtime. This open-label, randomized, parallel group, multicenter study investigated whether insulin glargine is equal
Autor:
Karin Schindler, Norbert Rosenthal, M Schramm, Walid Haddad, Ralf Jung, Rudolf A. Weiner, Arthur Bohdjalian, Bernhard Ludvik, Gerhard Prager, Christoph Rosak, Ricardo Aviv
Publikováno v:
Obesity surgery. 19(9)
Gastric electrical stimulation synchronized to the refractory period of gastric electrical activity and applied during meals was evaluated for safety and for improvement of body weight and glycemic control in obese type 2 diabetes.The study involved
Autor:
Sabine, Fischer, Christoph, Rosak
Publikováno v:
Zeitschrift fur arztliche Fortbildung und Qualitatssicherung. 96(3)
Changes to nutritional habits, including the reduction of weight, are basic therapy principles for the treatment of diabetes mellitus. With overweight patients a reduction of energy intake is important. Patients with diabetes mellitus should eat plen
The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents
Autor:
Christoph Rosak
Publikováno v:
Journal of diabetes and its complications. 16(1)
Type 2 diabetes results from the abnormal resistance of peripheral tissues to insulin and from the progressive insulin secretory failure of the pancreatic beta-cells. Treatment of type 2 diabetes has greatly improved due to the availability of new cl
Autor:
Gerhard Buchholz, Lothar Demisch, Peter Althoff, Kalus Demisch, Walter Magnet, Christoph Rosak
Publikováno v:
Psychiatry the State of the Art ISBN: 9781461294467
Pirlindole is an antidepressive drug apparently acting by reversible inhibition of the monoamine oxidase type A in the central nervous system. Its preferential substrates are serotonin and norepinephrine. Changes in the levels of these amines in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b04ee334424e4bc80db77e277e86b554
https://doi.org/10.1007/978-1-4613-2363-1_34
https://doi.org/10.1007/978-1-4613-2363-1_34
Publikováno v:
Thyroid Autoimmunity ISBN: 9781461282587
Graves’ disease is a HLA-linked autoimmune disease associated with certain HLA antigens, mainly with the HLA class II antigen HLA-DR 3 (7). Aberrant expression of HLA class II antigens on thyroidal cells was reported recently and was suggested to m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2238b017bfb3a145c0475f06698c8dda
https://doi.org/10.1007/978-1-4613-0945-1_87
https://doi.org/10.1007/978-1-4613-0945-1_87